Get the Stockscreener App
4.10
13.87%
-0.66
After Hours:
3.55
-0.55
-13.41%
Shuttle Pharmaceuticals Holdings Inc stock is traded at $4.10, with a volume of 1.95M.
It is down -13.87% in the last 24 hours and up +18.84% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical-stage pharmaceutical company leveraging its proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments with surgery, radiation therapy, chemotherapy and immunotherapy. Radiation therapy (RT) is one of the effective modalities for treating cancers. It is developing a pipeline of products designed to address the limitations of the current cancer therapies as well as to extend to the new applications of RT. The company believes that its product candidates will enable the company to deliver cancer treatments that are safer, more reliable and at a greater scale than that of the current standard of care.
See More
Previous Close:
$4.76
Open:
$5.58
24h Volume:
1.95M
Relative Volume:
13.99
Market Cap:
$4.39M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-8.913
EPS:
-0.46
Net Cash Flow:
$-5.48M
1W Performance:
-8.48%
1M Performance:
+18.84%
6M Performance:
-60.48%
1Y Performance:
-85.23%
1-Day Range:
$3.30
$5.59
1-Week Range:
$3.30
$5.59
52-Week Range:
$3.00
$56.25
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Compare SHPH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SHPH
Shuttle Pharmaceuticals Holdings Inc
|
4.10 | 5.10M | 0 | -7.35M | -5.48M | -0.46 |
|
ZTS
Zoetis Inc
|
141.11 | 63.55B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.71 | 44.47B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.00 | 40.17B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.03 | 22.99B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.00 | 20.14B | 3.08B | 1.24B | 1.07B | 25.61 |
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals Holdings Inc. stock volume spike explainedJuly 2025 Selloffs & Breakout Confirmation Trade Signals - newser.com
Shuttle Pharmaceuticals Plans to Acquire Molecule.ai for $10 Million - MarketScreener
Shuttle Pharmaceuticals Signs LOI To Acquire AI Drug Discovery Firm Molecule.ai - Nasdaq
Shuttle Pharma signs letter of intent to acquire AI firm Molecule.ai - Investing.com
Shuttle Executes LOI with Molecule.ai - Benzinga
$10M LOI: Shuttle Pharmaceuticals to acquire Molecule.ai, adds Agentic AI and drug‑target modeling - Stock Titan
Morning Market Movers: INTS, SHPH, CARM Spark Moves - RTTNews
Volatility clustering patterns for Shuttle Pharmaceuticals Holdings Inc.July 2025 Patterns & Risk Controlled Daily Plans - newser.com
Can technical indicators confirm Shuttle Pharmaceuticals Holdings Inc.’s reversalRate Hike & Low Risk Investment Opportunities - newser.com
Real time scanner hits for Shuttle Pharmaceuticals Holdings Inc. explainedMarket Activity Summary & Safe Investment Capital Preservation Plans - newser.com
Shuttle Pharmaceuticals signs letter of intent to acquire Molecule.ai By Investing.com - Investing.com Nigeria
Quarterly Losses And Deals Send Biotech Shares Sliding - Finimize
Shuttle Pharmaceuticals signs letter of intent to acquire Molecule.ai - Investing.com
Shuttle Pharmaceuticals stock soars after AI acquisition letter of intent By Investing.com - Investing.com Australia
Shuttle Pharmaceuticals stock soars after AI acquisition letter of intent - Investing.com
Shuttle Pharmaceuticals Holdings, Inc. Announces Non-Binding Letter of Intent to Acquire Molecule.ai for AI-Driven Drug Discovery Innovation - Quiver Quantitative
Shuttle to Enter $3.24 Billion AI Pharmaceutical Market - GlobeNewswire
$3.24B AI Pharma Market: Shuttle to Acquire Molecule.ai for $10M via LOI; Adds Agentic AI Mode - Stock Titan
Will Shuttle Pharmaceuticals Holdings Inc. price bounce be sustainable2025 Historical Comparison & Weekly Setup with High ROI Potential - newser.com
Shuttle Pharmaceuticals (NASDAQ:SHPH) Stock Price Down 2.6% – Here’s What Happened - Defense World
Is a relief rally coming for Shuttle Pharmaceuticals Holdings Inc. holders2025 Volatility Report & Safe Capital Growth Plans - newser.com
Will breakout in Shuttle Pharmaceuticals Holdings Inc. lead to full recoveryEarnings Growth Summary & Weekly Market Pulse Updates - newser.com
Candlestick signals on Shuttle Pharmaceuticals Holdings Inc. stock todayPortfolio Growth Summary & Long-Term Growth Stock Strategies - newser.com
What moving averages say about Shuttle Pharmaceuticals Holdings Inc.Recession Risk & Consistent Growth Stock Picks - newser.com
Published on: 2025-10-03 02:51:52 - newser.com
Will Shuttle Pharmaceuticals Holdings Inc. see short term momentumWeekly Profit Analysis & Real-Time Chart Pattern Alerts - newser.com
ProShares Trust ProShares UltraShort Russell2000 stock volume spike explainedWeekly Investment Report & Safe Capital Growth Tips - newser.com
Shuttle Pharmaceuticals Signs Consulting Agreement with IR Agency - TipRanks
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.54%
1.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):